Search

SENIOR ACCOUNTANT - WEAR MANY HATS - PROVEN RECRUITING - SAN DIEGO, CA

Join one of San Diego's fastest growing publicly traded biotech companies as a Senior Accountant. Public company experience preferably...

RESEARCH STUDY COORDINATOR

Job Description Research Study Coordinator and Conference Coordinator in Non-Profit Research Organization About The Organization The...

 
 
 

PRINCIPAL RESEARCH SCIENTIST - ELI LILLY - SAN DIEGO, CA

This experienced senior scientist research position resides at the Lilly Biotechnology Center-San Diego in the department of Biotechnology...

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

BIO ROUNDUP: ELI LILLY TRIES TAU, GENERIC INSULIN, NASH CASH & MORE

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used...

 
 
 
Interactive Map Displays Strength of Industry's National Footprint

INTERACTIVE MAP DISPLAYS STRENGTH OF INDUSTRY'S NATIONAL FOOTPRINT

BIO's biennial economic development and jobs report focuses on the economic progress and national footprint of the bioscience industry....

Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer's

ELI LILLY PARTNERS WITH AC IMMUNE ON TAU BLOCKERS FOR ALZHEIMER'S

There's at least one major pharmaceutical company that isn't giving up yet on finding an Alzheimer's disease drug. Eli Lilly is pairing...

 
 
 
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

TO COVER DEBTS, SYNERGY INKS $200M BANKRUPTCY SALE TO BAUSCH HEALTH

Synergy Pharmaceuticals has spent years looking for a buyer. The developer of a struggling drug for two types of chronic constipation...

Administration stops NIH scientists from obtaining fetal tissue, possibly threatening HIV research

ADMINISTRATION STOPS NIH SCIENTISTS FROM OBTAINING FETAL TISSUE, POSSIBLY THREATENING HIV RESEARCH

Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between...

 
 
 
Black Diamond Emerges with $20M, Aiming for Cancer's Hidden Targets

BLACK DIAMOND EMERGES WITH $20M, AIMING FOR CANCER'S HIDDEN TARGETS

Nearly two years ago, Versant Ventures used some of its new $400 million fund to set up a drug discovery unit in Europe. The goal was...

HIGH SCHOOL SCIENCE TUTOR/TEACHING ASSISTANT

Biotech Partners is an award-winning non-profit organization that coordinates a comprehensive hands-on science-based education and...

 
 
 

ENGINEER 1, PRODUCT LIFECYCLE - ILLUMINA - SAN DIEGO, CA

Work experience in biotech or medical device field is a plus. The person in this role will be supporting LCM instruments and development...

97023 LAB ASSISTANT

DIVISION OF BIOLOGICAL SCI. Hiring Salary Range: $17.23 - $18.57 / HourFiling Deadline: Mon 12/24/2018...

 
 
 

BIOTECH JOB TRAINING

Are you interested in getting the skills biotech employers want? The biomanufacturing program at Laney College in Oakland offers hands-on...

 
 
 
Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

IMFINZI LOOKS FLIMSY IN ASTRAZENECA'S PHASE III HEAD AND NECK CANCER STUDY

Results of the Phase III EAGLE study leave Merck's Keytruda and Bristol's Opdivo as the dominant players in the space of HNSCC after...

DISTRICT INSIDE SALES REPRESENTATIVE - ILLUMINA - SAN DIEGO, CA

Illumina provides this opportunity to driven, energetic and solution-providing professionals who are looking to begin or advance their...

 
 
 
LunaDNA Offers Stock for Data in Bid to Build Research Database

LUNADNA OFFERS STOCK FOR DATA IN BID TO BUILD RESEARCH DATABASE

Henrietta Lacks' “immortal cells” contributed enormously to the progression of scientific discovery, but Lacks, a poor, black woman...

Moderna just priced the biggest IPO in biotech history, valuing the startup at $7.5 billion

MODERNA JUST PRICED THE BIGGEST IPO IN BIOTECH HISTORY, VALUING THE STARTUP AT $7.5 BILLION

Moderna Therapeutics, a buzzy startup with a heady private valuation, filed paperwork in November to go public. On Thursday, the biotech...

 
 
 
Brii Bio's Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline

BRII BIO'S ALLIANCE WITH VBI VACCINES ADDS HEPATITIS B DRUG TO PIPELINE

Brii Biosciences launched earlier this year with $260 million and a mission to find new medicines in infectious disease and other therapeutic...

Impel Raises $67.5M to Advance Intranasal Drugs for CNS Disorders

IMPEL RAISES $67.5M TO ADVANCE INTRANASAL DRUGS FOR CNS DISORDERS

Impel NeuroPharma , which is developing technology to deliver certain therapeutics more effectively to the brain, says it has raised...